| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Scientific Officer | Chief Research Officer
1 company
Shoemaker Daniel D is a Chief Scientific Officer at FATE THERAPEUTICS INC. Recent SEC Form 4 filings include 0 buys and 29 sells.
Estimated insider holdings value: $164K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Mar 8, 2021 | FATE Fate Therapeutics Inc | Chief Scientific Officer | Sell | 25,000 | $81.74 | $2,043,428.24 | -3.7% | |
| Jan 11, 2021 | FATE Fate Therapeutics Inc | Chief Scientific Officer | Sell | 9,482 | $114.95 | $1,089,911.48 | -1.5% | |
| Nov 16, 2020 | FATE Fate Therapeutics Inc | Chief Scientific Officer | Sell | 25,000 | $51.83 | $1,295,745.71 | -7.4% | |
| Sep 14, 2020 | FATE Fate Therapeutics Inc | Chief Scientific Officer | Sell | 25,000 | $36.30 | $907,539.56 | -6.1% | |
| Jan 8, 2020 | FATE Fate Therapeutics Inc | Chief Scientific Officer | Sell | 5,700 | $20.70 | $117,986.01 | -3.8% | |
| Dec 30, 2019 | FATE Fate Therapeutics Inc | Chief Scientific Officer | Sale+OE | 25,000 | $19.50 | $487,427.13 | -9.2% | |
| Oct 15, 2019 | FATE Fate Therapeutics Inc | Chief Scientific Officer | Sell | 11,800 | $14.29 | $168,592.50 | -8.7% | |
| Jun 27, 2019 | FATE Fate Therapeutics Inc | Chief Scientific Officer | Sale+OE | 12,500 | $20.21 | $252,610.00 | -8.4% | |
| Mar 28, 2019 | FATE Fate Therapeutics Inc | Chief Scientific Officer | Sale+OE | 12,500 | $16.94 | $211,702.50 | -8.4% | |
| Oct 16, 2017 | FATE Fate Therapeutics Inc | Chief Scientific Officer | Sell | 13,225 | $3.87 | $51,202.50 | -6.8% |